Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.18 -0.78 (-1.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Share-based Compensation (2010 - 2026)

Updated

Ani Pharmaceuticals' Share-based Compensation was $11.41 million in Q2 2026, up 18.8% from $9.6 million a year earlier and up 11.9% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Share-based Compensation (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ani Pharmaceuticals' Share-based Compensation was $41.06 million through Jun 30, 2026, up 24.4% year-over-year; for FY2025, it was $37.93 million, up 29.3% from FY2024.

  • Share-based Compensation has now increased for four consecutive years, with a five-year compound annual growth rate of 24.0% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $29.34 million in FY2024 (+42.1%), $20.65 million in FY2023 (+41.5%), $14.6 million in FY2022 (+39.2%) and $10.49 million in FY2021 (-18.9%).
  • The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q3 2010.
  • Compared with a year earlier, Share-based Compensation has increased for 20 straight quarters, with growth averaging 26.8% over the last eight quarters.
  • The year-over-year growth in Share-based Compensation has ranged between 14.9% (Q1 2026) and 73.2% (Q1 2022) over the last five years.
  • Per Business Quant data, ANIP's Share-based Compensation in the three quarters before Q2 2026 was $10.19 million (Q1 2026), $9.77 million (Q4 2025) and $9.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 458.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 166.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 231.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 249.00 Mn
10 Ani Pharmaceuticals 1.74 Bn 520.73 Mn 165.89 Mn 11.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.41 Mn
Mar 31, 2026 10.19 Mn
Dec 31, 2025 9.77 Mn
Sep 30, 2025 9.69 Mn
Jun 30, 2025 9.60 Mn
Mar 31, 2025 8.87 Mn
Dec 31, 2024 7.06 Mn
Sep 30, 2024 7.49 Mn
Jun 30, 2024 7.86 Mn
Mar 31, 2024 6.93 Mn
Dec 31, 2023 5.62 Mn
Sep 30, 2023 5.44 Mn
Jun 30, 2023 5.25 Mn
Mar 31, 2023 4.34 Mn
Dec 31, 2022 3.74 Mn
Sep 30, 2022 3.87 Mn
Jun 30, 2022 3.76 Mn
Mar 31, 2022 3.24 Mn
Dec 31, 2021 2.97 Mn
Sep 30, 2021 2.81 Mn
API Access

Ani Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ANIP&period=max&api_key=YOUR_API_KEY